Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 3, 2003, Pages 587-591

  Watanabe, Shinichi ^a   Narisawa, Yutaka ^b   Arase, Seiji ^c   Okamatsu, Hiroshi ^d   Ikenaga, Takeshi ^d   Tajiri, Yoshito ^d   Kumemura, Megumi ^d  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Allergy; Atopic dermatitis; Bacteroides; Bifidobacterium; Case control study; Fecal IgA; Microflora; Minority; Skin IgA; Staphylococcus

Indexed keywords

IMMUNOGLOBULIN A;

ARTICLE; ATOPIC DERMATITIS; BACTERIAL COUNT; BIFIDOBACTERIUM; CASE CONTROL STUDY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FECES MICROFLORA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SKIN MANIFESTATION; STAPHYLOCOCCUS;

EID: 0037339153     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.105     Document Type: Article

References (29)

1. Larssen, FS, Holm, NV, Henningsen K. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-94.
2. Lasen FS, Diepgen T, Svensson A. The occurrence of atopic dermatitis in North Europe: an international questionnaire study. J Ann Acad Dermatol 1996;34:760-4.
3. Holgate ST. The epidemic of allergy and asthma. Nature 1999;402 (suppl):B2-4.
4. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999;354(suppl 2):12-5.
5. Holt PG, Macaubas C, Prescott SL, Sly PD. Microbial stimulation as an aetiologic factor in atopic disease. Allergy 1999;54:12-6.
6. Wold AE. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 1998;53(suppl 46):20-5.
7. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal flora for the development of an IgE production system fully susceptible to pral tolerance induction. J Immunol 1997;159:1739-45.
8. Björkstén B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342-6.
9. Böttcher MF, Nordin EK, Sandin A, Midtvedt T, Björstón B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000;30:1590-6.
10. Kalliomöki M, Kirjavainen P, Eekki E, Kero P, Salmonen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-34.
11. Takeuchi M, Ueda H. Increase of adult atopic dermatitis (AD) in recent Japan. Environ Dermatitis 2000;7:133-6.
12. Tagami H. Japanese Dermatological Association Criteria for the Diagnosis of Atopic Dermatitis. J Dermatol 1995;22:966-7.
13. Mitsuoka T. A color atlas of anaerobic bacteria. Tokyo: Sobunsya; 1980. p. 341.
14. Tsuyuki S, Yamazaki S, Kamimura H, Kimura M, Kawashima T, Ueda K. An enzyme-linked immunosorbent assay for measuring IgA antibody and total IgA in bile and small intestinal contents of mice. Bifidus 1988;2:9-13.
15. Imayama S, Shimozono Y, Urabe A, Hori Y. A simple method for measuring the amount of immunoglobulin A secreted onto the skin surface. Acta Derm Venereol 1995;75:212-7.
16. Bjorksten B, Sepp E, Julge K, Boor T, Mikelsaar M. Allergy development and the intestinal microbflora during the first year of life. J Allergy Clin Immunol 2001;108:516-20.
17. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001;107:531-4.
18. Benno Y, Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobacteria Microflora 1986;5:13-25.
19. Mitsuoka T. Intestinal flora and aging. Nutr Rev 1992;50:438-46.
20. Holdeman LV, Good IJ, Moore WEC. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ microbiol 1976;31:359-75.
21. Levitan MC, Marco OP. Intestinal microflora in patients with Crohn's disease and ulcerative colitis. Am J Proctology 1976;27:49-54.
22. Kanazawa K, Konishi F, Mitsuoka T, Terada A, Itoh K, Narushima S, et al. Factors influencing the development of sigmoid colon cancer, bacteriologic and biochemical studies. Cancer 1996;77:1701-6.
23. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-30.
24. Bunikowski R, Mielke MEA, Skambis H, Worm M, Anagnostopoulos J, Kolde G, et al. Evidence for a disease promoting effect or S. aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105:814-9.
25. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-76.
26. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002;109:379-92.
27. Iikura Y, Ebisawa H, Akazawa A, Akigi K, Iikura N. Study on infantile atopic dermatitis. Immunological background of atopic dermatitis. Prog Med 1989;9:1803-7.
28. Imayama S, Shimozono Y, Hoashi M, Yasumoto S, Ohta S, Yoneyama K, et al. Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 1994;94:195-200.
29. Kalliomäki M, Saliminen S, Arvilommi H, Kero P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.